FENC Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Fennec Pharmaceuticals Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 9.23 USD 1.54%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast FENC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FENC is 18.7 USD with a low forecast of 16.16 USD and a high forecast of 23.1 USD.

FENC Lowest Forecast

Wall Street Target

FENC Average Forecast

Wall Street Target

FENC Highest Forecast

Wall Street Target

75% Upside

103% Upside

150% Upside

The latest public price target was made on Apr 4, 2024 by Raghuram Selvaraju from H.C. Wainwright , who expects FENC stock to rise by 95% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst	Price Target	Date	Article
Raghuram Selvaraju H.C. Wainwright	18 USD Upside 95%	1 month ago Apr 4, 2024	Fennec price target raised to $18 from $17 at H.C. Wainwright TheFly
Chase Knickerbocker Craig-Hallum	18 USD Upside 95%	1 month ago Mar 19, 2024	Fennec Pharmaceuticals Inc. (FENC) PT Raised to $18 at Craig-Hallum StreetInsider

Price Target	18 USD
Upside/Downside	95%

Price Target	18 USD
Upside/Downside	95%

Genetron Holdings Ltd

67% Downside

Ascletis Pharma Inc

114% Upside

BioLine RX Ltd

80% Downside

Turnstone Biologics Corp

388% Upside

Genetron Holdings Ltd

67% Downside

Ascletis Pharma Inc

114% Upside

BioLine RX Ltd

80% Downside

Turnstone Biologics Corp

388% Upside

Krystal Biotech Inc

19% Upside

Sino Biological Inc

48% Upside

SK Bioscience Co Ltd

4% Downside

Y-mAbs Therapeutics Inc

27% Upside

Revenue
Forecast

The compound annual growth rate of Fennec Pharmaceuticals Inc's revenue for the next 3 years is 69%.

N/A

69%

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

0%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-22%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for FENC is 18.7 USD with a low forecast of 16.16 USD and a high forecast of 23.1 USD.

The compound annual growth rate of Fennec Pharmaceuticals Inc's revenue for the next 3 years is 69%.

Join more than 134,200+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.